Abstract
Purpose: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. Patients and Methods: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. Results: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. Conclusions: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.
Original language | English (US) |
---|---|
Pages (from-to) | e160-e162 |
Journal | Journal of glaucoma |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - 2017 |
Keywords
- VEGF
- bevacizumab
- membrane
- neovascular
- pupillary
ASJC Scopus subject areas
- Ophthalmology